PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Finding new ways to make drugs

Chemists have developed a revolutionary way to manufacture natural chemicals by clipping smaller molecules together like Lego. They used the new method to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria, pseudopterosin

Finding new ways to make drugs
2014-11-18
(Press-News.org) Chemists have developed a revolutionary new way to manufacture natural chemicals and used it to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria.

The breakthrough could lead to new and cheaper ways to produce rare drugs in large quantities.

"We took small molecules and clipped them together like Lego," said lead researcher Professor Michael Sherburn, from the Research School of Chemistry at The Australian National University (ANU).

"The building blocks are carefully designed in such a way that the first reaction generates a product perfectly primed for the second. It's quite magical. This means you can efficiently build large and complex molecules."

Medicines of this type have traditionally been made in a cumbersome way. Chemists take a related molecule and renovate it. This is a lengthy process, with unwanted structural features being ripped out and replaced.

"This leads to a lot of waste," Professor Sherburn said.

The group trialed their innovative new method by making pseudopterosin, a powerful anti-inflammatory and analgesic drug, which is currently only available in tiny quantities extracted from fan coral found in the Bahamas.

The work began as blue-sky research, with the researchers trying to work out a way to make supposedly impossible molecules of cross-conjugated hydrocarbons.

Before trying the experiments the team ran simulations on the Raijin supercomputer, which indicated that their method had potential.

"Ours is an empowering and enabling technique, allowing a smarter and faster way to make important substances," said Dr Chris Newton, who did the research in the laboratory as a PhD student.

"The pseudopterosin synthesis is the tip of the iceberg. We are well on the way to efficient syntheses of other important drugs.

"There is a potential for industrial-scale manufacture, too, which will take the pressure off species which are being harvested for drugs," he said.

INFORMATION:


[Attachments] See images for this press release:
Finding new ways to make drugs

ELSE PRESS RELEASES FROM THIS DATE:

History's lesson reveals depth of fish catch decline

Historys lesson reveals depth of fish catch decline
2014-11-18
Scientists in Australia have used historic media to measure the decline in Queensland's pink snapper fishery, highlighting a drop of almost 90 per cent in catch rates since the 19th Century. Researchers from the ARC Centre of Excellence for Coral Reef Studies (Coral CoE) at the University of Queensland and the Department of Agriculture Fisheries and Forestry examined thousands of newspaper articles dating back to1870 to reveal the historic catch rates for the iconic Queensland fishery. "We found that 19th century recreational fishers would regularly catch hundreds of ...

Breakthrough offers promise for spinal cord injury patients to breathe on their own again

2014-11-18
Case Western Reserve researchers have developed a procedure that restores function to muscles involved in the control of breathing - even when they have been paralyzed for more than a year. The breakthrough offers hope that one day patients with severe spinal cord injuries will be able to breathe again without the assistance of a ventilator. Principal investigator Philippa M. Warren, PhD, presented the results Nov. 17 at Neuroscience 2014, the annual meeting of the Society for Neuroscience. The research represents a critical step forward in efforts to reverse even long-term ...

Ferroptosis, a novel form of non-apoptotic cell death, holds great therapeutic potential

2014-11-18
Ferroptosis is a recently recognized form of regulated necrosis. Up until now, this form of cell death has only been thought to be a possible therapeutic approach to treat tumour cells. Yet, ferroptosis also occurs in non-transformed tissues as demonstrated by this study, thus implicating this cell death pathway in the development of a wide range of pathological conditions. More specifically, the deletion of the ferroptosis-regulating enzyme Gpx4* in a pre-clinical model results in high ferroptosis rates in kidney tubular epithelial cells causing acute renal failure. Specific ...

Risk analysis for a complex world

2014-11-18
The increasing complexity and interconnection of socioeconomic and environmental systems leaves them more vulnerable to seemingly small risks that can spiral out of control, according to the new study, published in the journal Proceedings of the National Academy of Sciences. The study examines risks are perceived as extremely unlikely or small, but because of interconnections or changes in systems, can lead to major collapses or crises. These risks, which the researchers term "femtorisks," can include individuals such as terrorists, dissidents, or rogue traders, or factors ...

Better micro-actuators to transport materials in liquids

2014-11-18
This news release is available in German. Scientists have been conducting research on micrometre-sized actuators which one day may make it possible to transport drugs or chemical sensor molecules to specific locations throughout the human body. Researchers at ETH Zurich have now taken the development of such micro-devices a crucial step forward: a new production technology and new materials have made it possible to manufacture tiny actuators in any form and optimise them for future applications. The elongated actuators elements, which can move through liquids, possess ...

New clue in celiac disease puzzle: Cause of oat toxicity explained

New clue in celiac disease puzzle: Cause of oat toxicity explained
2014-11-18
Melbourne researchers have identified why some people with coeliac disease show an immune response after eating oats. The researchers have identified the key components in oats that trigger an immune response in some people with coeliac disease. The findings may lead to better tests for oat toxicity, and have implications for new treatments being developed for coeliac disease. As many as one in 60 women and one in 80 men in Australia have coeliac disease, an autoimmune condition caused by consuming gluten, a protein found in wheat, rye and barley. The abnormal immune ...

'Being poor is not the same everywhere'

2014-11-18
Young people growing up in impoverished neighborhoods who perceive their poor communities in a positive light report better health and well-being than those with worse perceptions of where they live, new research led by the Johns Hopkins Bloomberg School of Public Health suggests. As part of the Well-Being of Adolescents in Vulnerable Environments (WAVE) study, researchers surveyed nearly 2,400 adolescents ages 15 to 19 in poor sections of five cities across the world: Baltimore; New Delhi, India; Ibadan, Nigeria; Johannesburg, South Africa; and Shanghai, China. The survey ...

Brain receptor cell could be new target for Alzheimer's

2014-11-18
Blocking a key receptor in brain cells that is used by oxygen free radicals could play a major role in neutralizing the biological consequences of Alzheimer's disease, according to researchers at Temple University. The researchers' findings, "Modulation of AD Neuropathology and Memory Impairments by the Isoprostane F2α Is Mediated by the Thromboxane Receptor," were published Oct. 13 by the journal Neurobiology of Aging. The human body's use of oxygen to produce energy often results in the formation of highly reactive molecules called oxygen free radicals. Oxidative ...

Unexpected cross-species contamination in genome sequencing projects

2014-11-18
As genome sequencing has gotten faster and cheaper, the pace of whole-genome sequencing has accelerated, dramatically increasing the number of genomes deposited in public archives. Although these genomes are a valuable resource, problems can arise when researchers misapply computational methods to assemble them, or accidentally introduce unnoticed contaminations during sequencing. The first complete bacterial genome, Haemophilus influenzae, appeared in 1995, and today the public GenBank database contains over 27,000 prokaryotic and 1,600 eukaryotic genomes. The vast majority ...

Twenty-five year hunt uncovers heart defect responsible for cardiovascular diseases

2014-11-18
The landmark discovery of a tiny defect in a vital heart protein has for the first time enabled heart specialists to accurately pinpoint a therapeutic target for future efforts in developing a drug-based cure for cardiovascular diseases. Scientists from Cardiff University and the Slovak Academy of Science have identified defects in a colossal heart protein which often leads to stroke and heart failure. "Our research has revealed that a genetic alteration in the largest membrane protein, responsible for triggering each and every heartbeat, produces a small structural ...

LAST 30 PRESS RELEASES:

Fecal microbiome and bile acid profiles differ in preterm infants with parenteral nutrition-associated cholestasis

The Institute of Science and Technology Austria (ISTA) receives €5 million donation for AI research

Study finds link between colorblindness and death from bladder cancer

Tailored treatment approach shows promise for reducing suicide and self-harm risk in teens and young adults

Call for papers: AI in biochar research for sustainable land ecosystems

Methane eating microbes turn a powerful greenhouse gas into green plastics, feed, and fuel

Hidden nitrogen in China’s rice paddies could cut fertilizer use

Texas A&M researchers expose hidden risks of firefighter gear in an effort to improve safety and performance

Wood burning in homes drives dangerous air pollution in winter

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: January 23, 2026

ISSCR statement in response to new NIH policy on research using human fetal tissue (Notice NOT-OD-26-028)

Biologists and engineers follow goopy clues to plant-wilting bacteria

What do rats remember? IU research pushes the boundaries on what animal models can tell us about human memory

Frontiers Science House: did you miss it? Fresh stories from Davos – end of week wrap

Watching forests grow from space

New grounded theory reveals why hybrid delivery systems work the way they do

CDI scientist joins NIH group to improve post-stem cell transplant patient evaluation

Uncovering cancer's hidden oncRNA signatures: From discovery to liquid biopsy

Multiple maternal chronic conditions and risk of severe neonatal morbidity and mortality

Interactive virtual assistant for health promotion among older adults with type 2 diabetes

Ion accumulation in liquid–liquid phase separation regulates biomolecule localization

Hemispheric asymmetry in the genetic overlap between schizophrenia and white matter microstructure

Research Article | Evaluation of ten satellite-based and reanalysis precipitation datasets on a daily basis for Czechia (2001–2021)

Nano-immunotherapy synergizing ferroptosis and STING activation in metastatic bladder cancer

Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor

Combined aerobic-resistance exercise: Dual efficacy and efficiency for hepatic steatosis

Expert consensus outlines a standardized framework to evaluate clinical large language models

Bioengineered tissue as a revolutionary treatment for secondary lymphedema

Forty years of tracking trees reveals how global change is impacting Amazon and Andean Forest diversity

Breathing disruptions during sleep widespread in newborns with severe spina bifida

[Press-News.org] Finding new ways to make drugs
Chemists have developed a revolutionary way to manufacture natural chemicals by clipping smaller molecules together like Lego. They used the new method to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria, pseudopterosin